DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Mosenzon O, Blicher TM, Rosenlund S. et al.
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and
moderate renal impairment (PIONEER 5): A placebo-controlled, randomised, phase
3a trial.
Lancet Diabetes Endocrinol 2019;
7: 515-527
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.